Multicentric hepatocellular carcinoma following phosphate diethylstilbestrol therapy for prostatic cancer.
This paper reports an autopsy case of a 78-year-old male with multiple nodules in the liver developed after long-termed administration of phosphate diethylstilbestrol (PDES) for prostatic cancer. Large part of these nodules were suspected to be well differentiated hepatocellular carcinoma with high level of serum alpha-fetoprotein (AFP) up to 3,400 ng/ml, but a part of them was evaluated to be a borderline between hepatocellular carcinoma and adenoma with mild cellular atypism. The liver other than the nodules showed liver fibrosis associated with liver cell dysplasia and peliosis hepatis-like change. This is a unique autopsy case of hepatocellular carcinoma closely related to diethylstilbestrol (DES) therapy for prostatic cancer.
D000236:Adenoma / Q000473:pathology / Q000556:secondary; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000556:secondary*; D004054:Diethylstilbestrol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008099:Liver / Q000473:pathology; D008113:Liver Neoplasms / Q000473:pathology / Q000556:secondary*; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000509:alpha-Fetoproteins / Q000032:analysis
D000509:alpha-Fetoproteins; C048587:diethylstilbestrol monophosphate; D004054:Diethylstilbestrol